M1 Kliniken AG Appoints Katharina Zimmnau to Executive Board, Strengthening Financial Leadership

The Supervisory Board of M1 Kliniken AG has appointed Katharina Zimmnau to the Executive Board of the company, effective December 10, 2025. Zimmnau has served as Chief Financial Officer of M1 Kliniken AG since June 1, 2025. This appointment represents a significant step in consolidating the company's financial leadership as it pursues an aggressive growth strategy in the competitive medical aesthetics market.

Attila Strauss, CEO of M1 Kliniken AG, expressed strong support for the appointment, stating that Zimmnau's extensive background in accounting, controlling, and process design will be instrumental in guiding the company's continued profitable growth. Her promotion to the Executive Board signals the company's commitment to strengthening its financial oversight and strategic planning capabilities at the highest level of management.

M1 Kliniken AG operates as the leading fully integrated provider of medical aesthetic services across Europe and Australia, with a network of 58 clinics in ten countries under the M1 Med Beauty brand. The company's expansion strategy, which began in late 2018, has focused on high standardization and consistent scalability to support sustainable growth. All treatments are performed exclusively by qualified physicians adhering to uniform medical standards while maintaining market-leading pricing.

The company's flagship facility, the M1 Schlossklinik in Berlin, represents one of Europe's largest and most modern clinics for plastic and aesthetic surgery, featuring four operating theaters and 35 beds. This infrastructure supports the company's position in the premium segment of the medical aesthetics market. The appointment of Zimmnau to the Executive Board coincides with a period of continued international expansion for the company, which views scalable growth as fundamental to developing its global market position further.

This leadership development comes as the medical aesthetics industry experiences increasing demand and competitive pressures. By elevating its CFO to the Executive Board, M1 Kliniken AG demonstrates a strategic focus on financial discipline and operational efficiency as cornerstones of its expansion model. The move suggests confidence in Zimmnau's ability to contribute to both immediate financial management and long-term strategic direction, particularly as the company navigates the complexities of operating across multiple international markets.

The full details of the appointment were made available through the original release on www.newmediawire.com. This board-level change reflects the company's ongoing evolution from a regional operator to an international player in medical aesthetics, with financial expertise playing a crucial role in managing that transition. The appointment reinforces the importance of financial leadership in healthcare companies pursuing aggressive growth strategies while maintaining quality standards and operational consistency across diverse markets.